These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19822833)

  • 1. Adverse events in patients receiving cholinesterase inhibitors due to dissimilar follow-up periods.
    Chan M
    Arch Intern Med; 2009 Oct; 169(18):1724; author reply 1724-5. PubMed ID: 19822833
    [No Abstract]   [Full Text] [Related]  

  • 2. Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study.
    Gill SS; Anderson GM; Fischer HD; Bell CM; Li P; Normand SL; Rochon PA
    Arch Intern Med; 2009 May; 169(9):867-73. PubMed ID: 19433698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donepezil: syncope. Various cardiac disorders.
    Prescrire Int; 2008 Jun; 17(95):113. PubMed ID: 18630357
    [No Abstract]   [Full Text] [Related]  

  • 4. Syncope with cholinesterase inhibitors.
    Prescrire Int; 2011 Oct; 20(120):240. PubMed ID: 21970087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donepezil and cardiac syncope: case report.
    Jane Newby V; Anne Kenny R; McKeith IG
    Int J Geriatr Psychiatry; 2004 Nov; 19(11):1110-2. PubMed ID: 15497193
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cholinesterase inhibitors in dementia: the precarious balance between efficacy and safety].
    Richard E; van Gool WA
    Ned Tijdschr Geneeskd; 2006 Mar; 150(10):530-2. PubMed ID: 16566413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A reply to Pfizer: Still no reason to change SBU's conclusions on drugs against dementia].
    Edhag O; Norlund A
    Lakartidningen; 2007 Jan 10-16; 104(1-2):55. PubMed ID: 17323745
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cardiac effects of cholinesterase inhibitors: a reason for restraint?].
    Salarbaks AM; Boomkamp-Snoeren CM; van Puijenbroek E; Jansen PA; van Marum RJ
    Tijdschr Gerontol Geriatr; 2009 Apr; 40(2):79-84. PubMed ID: 19472574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between cholinesterase inhibitors and Pisa syndrome in a cohort of five French patients with Alzheimer's disease.
    Huvent-Grelle D; Roche J; Camus FE; Dewailly P; Puisieux F
    J Am Geriatr Soc; 2007 Sep; 55(9):1472-5. PubMed ID: 17767692
    [No Abstract]   [Full Text] [Related]  

  • 10. [Paroxysmal atrioventricular block due to anticholinesterase therapy].
    Brembilla-Perrot B; Regent MC; Hanesse B; Maheut-Bosser A; Schmal Laurain MC; Lemoine J; Popovic B; Tréchot P
    Arch Mal Coeur Vaiss; 2004 Dec; 97(12):1265-7. PubMed ID: 15669371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mania after administration of cholinesterase inhibitors in patients with dementia and comorbid bipolar disorder: two case reports.
    Ehrt U; Fritze F; Aarsland D
    J Clin Psychopharmacol; 2011 Apr; 31(2):254-6. PubMed ID: 21364344
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of drugs against dementia].
    Engedal K; Braekhus A; Gjerstad L
    Tidsskr Nor Laegeforen; 2004 Jun; 124(12):1641-2. PubMed ID: 15229711
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cholinesterase inhibitors in Alzheimer disease; preliminary recommendations for the practice].
    Van Zwieten-Boot BJ; Lekkerkerker JF
    Ned Tijdschr Geneeskd; 1998 Nov; 142(48):2644-5; author reply 2645-6. PubMed ID: 10028368
    [No Abstract]   [Full Text] [Related]  

  • 14. ACP Journal Club. Review: cholinesterase inhibitors but not memantine increase syncope in older adults with mild cognitive impairment or dementia.
    Ng B
    Ann Intern Med; 2011 Nov; 155(10):JC5-10. PubMed ID: 22084357
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dementia is to be investigated and treated].
    Braendgaard H; Jakobsen JK
    Ugeskr Laeger; 2003 Feb; 165(6):551. PubMed ID: 12608019
    [No Abstract]   [Full Text] [Related]  

  • 16. SIGN guideline for the management of patients with dementia.
    Connelly PJ; James R
    Int J Geriatr Psychiatry; 2006 Jan; 21(1):14-6. PubMed ID: 16353165
    [No Abstract]   [Full Text] [Related]  

  • 17. Involuntary weight loss associated with cholinesterase inhibitors in dementia.
    Stewart JT; Gorelik AR
    J Am Geriatr Soc; 2006 Jun; 54(6):1013-4. PubMed ID: 16776808
    [No Abstract]   [Full Text] [Related]  

  • 18. Strategies to improve tolerability of rivastigmine: a case series.
    Venkatesh K; Bullock R; Akbaş A
    Curr Med Res Opin; 2007 Jan; 23(1):93-5. PubMed ID: 17257470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinesterase inhibitors in dementia: yes, no, or maybe?
    Lemstra AW; Richard E; van Gool WA
    Age Ageing; 2007 Nov; 36(6):625-7. PubMed ID: 17881419
    [No Abstract]   [Full Text] [Related]  

  • 20. Applications of cholinesterase inhibitors.
    Haussermann P; Ceballos-Baumann A; Reinbold H; Goecker D; Schröder S
    Lancet; 2001 Mar; 357(9261):1039. PubMed ID: 11293614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.